메뉴 건너뛰기




Volumn 26, Issue 3, 1998, Pages 257-260

Inhibition of methadone and buprenorphine N-dealkylations by three HIV- 1 protease inhibitors

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; BUPRENORPHINE; CYTOCHROME P450; INDINAVIR; METHADONE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

EID: 0031942863     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (117)

References (27)
  • 2
    • 0030895312 scopus 로고    scopus 로고
    • Protease inhibitors in patients with HIV disease: Clinically important pharmacokinetic considerations
    • Barry M, Gibbons S, Back D and Mulcahy F (1997) Protease inhibitors in patients with HIV disease: Clinically important pharmacokinetic considerations. Clin Pharmacokinet 32:194-209.
    • (1997) Clin Pharmacokinet , vol.32 , pp. 194-209
    • Barry, M.1    Gibbons, S.2    Back, D.3    Mulcahy, F.4
  • 3
    • 0025848751 scopus 로고
    • Evidence for the involvement of several cytochrome P450s in the first-step of caffeine metabolism by human liver microsomes
    • Berthou F, Flinois JP, Ratanasavanh D, Beaune P, Riché C and Guillouzo A (1991) Evidence for the involvement of several cytochrome P450s in the first-step of caffeine metabolism by human liver microsomes. Drug Metab Dispos 19:561-567.
    • (1991) Drug Metab Dispos , vol.19 , pp. 561-567
    • Berthou, F.1    Flinois, J.P.2    Ratanasavanh, D.3    Beaune, P.4    Riché, C.5    Guillouzo, A.6
  • 4
    • 0028232498 scopus 로고
    • Involvement of cytochrome P450 3A4 enzyme family in the major metabolic pathways of toremifene in human liver microsomes
    • Berthou F, Dréano Y, Belloc C, Kangas L, Gautier JC and Beaune P (1994) Involvement of cytochrome P450 3A4 enzyme family in the major metabolic pathways of toremifene in human liver microsomes. Biochem Pharmacol 47:1883-1895.
    • (1994) Biochem Pharmacol , vol.47 , pp. 1883-1895
    • Berthou, F.1    Dréano, Y.2    Belloc, C.3    Kangas, L.4    Gautier, J.C.5    Beaune, P.6
  • 5
    • 0030935086 scopus 로고    scopus 로고
    • Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions
    • Bertz RJ and Granneman GR (1997) Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clin Pharmacokinet 32:210-258.
    • (1997) Clin Pharmacokinet , vol.32 , pp. 210-258
    • Bertz, R.J.1    Granneman, G.R.2
  • 6
    • 0029872126 scopus 로고    scopus 로고
    • Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent HIV protease inhibitor
    • Chiba M, Hensleigh M, Nishime JA, Balani SK and Lin JH (1996) Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent HIV protease inhibitor. Drug Metab Dispos 24:307-314.
    • (1996) Drug Metab Dispos , vol.24 , pp. 307-314
    • Chiba, M.1    Hensleigh, M.2    Nishime, J.A.3    Balani, S.K.4    Lin, J.H.5
  • 7
    • 0030908131 scopus 로고    scopus 로고
    • Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor in rat and human microsomes: Major role of CYP3A
    • Chiba M, Hensleigh M and Lin JH (1997) Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor in rat and human microsomes: Major role of CYP3A. Biochem Pharmacol 53:1187-1195.
    • (1997) Biochem Pharmacol , vol.53 , pp. 1187-1195
    • Chiba, M.1    Hensleigh, M.2    Lin, J.H.3
  • 10
    • 27544457547 scopus 로고
    • A medical treatment for diacetylmorphine (heroine) addiction
    • Dole VP and Nyswander M (1965) A medical treatment for diacetylmorphine (heroine) addiction. JAMA 193:646-650.
    • (1965) JAMA , vol.193 , pp. 646-650
    • Dole, V.P.1    Nyswander, M.2
  • 11
    • 0030852009 scopus 로고    scopus 로고
    • Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir
    • Eagling VA, Back DJ and Barry MG (1997) Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir. Br J Clin Pharmacol 44:190-194.
    • (1997) Br J Clin Pharmacol , vol.44 , pp. 190-194
    • Eagling, V.A.1    Back, D.J.2    Barry, M.G.3
  • 12
    • 0031024382 scopus 로고    scopus 로고
    • Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small intestinal cytochrome P450 3A4: Potential contribution to high first-pass metabolism
    • Fitzsimmons ME and Collins JM (1997) Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small intestinal cytochrome P450 3A4: Potential contribution to high first-pass metabolism. Drug Metab Dispos 25:256-266.
    • (1997) Drug Metab Dispos , vol.25 , pp. 256-266
    • Fitzsimmons, M.E.1    Collins, J.M.2
  • 13
    • 0030428226 scopus 로고    scopus 로고
    • In vitro techniques for studying drug metabolism
    • Guengerich FP (1996) In vitro techniques for studying drug metabolism. J Pharmacokin Biopharm 24:521-533.
    • (1996) J Pharmacokin Biopharm , vol.24 , pp. 521-533
    • Guengerich, F.P.1
  • 15
    • 0030943931 scopus 로고    scopus 로고
    • Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver micromes
    • Iribame C, Picart D, Dréano Y, Bail JP and Berthou F (1997a) Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver micromes. Life Sci 60:1953-1964.
    • (1997) Life Sci , vol.60 , pp. 1953-1964
    • Iribame, C.1    Picart, D.2    Dréano, Y.3    Bail, J.P.4    Berthou, F.5
  • 16
    • 0031566987 scopus 로고    scopus 로고
    • Interaction of methadone with substrates of human hepatic cytochrome P450 3A4
    • Iribarne C, Dréano Y, Bardou LG, Ménez JF and Berthou F (1997b) Interaction of methadone with substrates of human hepatic cytochrome P450 3A4. Toxicology 117:13-23.
    • (1997) Toxicology , vol.117 , pp. 13-23
    • Iribarne, C.1    Dréano, Y.2    Bardou, L.G.3    Ménez, J.F.4    Berthou, F.5
  • 17
    • 0025872863 scopus 로고
    • Identification of the cytochrome P450 IIIA family as the enzyme involved in the N-demethylation of tamoxifen in human liver microsomes
    • Jacolot F, Simon I, Dréano Y, Beaune PH, Riché C and Berthou F (1991) Identification of the cytochrome P450 IIIA family as the enzyme involved in the N-demethylation of tamoxifen in human liver microsomes. Biochem Pharmacol 41:1911-1919.
    • (1991) Biochem Pharmacol , vol.41 , pp. 1911-1919
    • Jacolot, F.1    Simon, I.2    Dréano, Y.3    Beaune, P.H.4    Riché, C.5    Berthou, F.6
  • 18
    • 0030430035 scopus 로고    scopus 로고
    • Cytochrome P450 medialed metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes
    • Kumar GN, Rodrigues AD, Buko AM and Denissen JF (1996) Cytochrome P450 medialed metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes. J Pharmacol Exp Ther 277:423-431.
    • (1996) J Pharmacol Exp Ther , vol.277 , pp. 423-431
    • Kumar, G.N.1    Rodrigues, A.D.2    Buko, A.M.3    Denissen, J.F.4
  • 19
    • 0029840569 scopus 로고    scopus 로고
    • Ritonavir
    • Lea P and Faulds D (1996) Ritonavir. Drugs 52:541-546.
    • (1996) Drugs , vol.52 , pp. 541-546
    • Lea, P.1    Faulds, D.2
  • 20
    • 0029584276 scopus 로고
    • Substrates of hepatic cytochrome P450 3A4
    • Li AP, Kaminski DL and Rasmussen A (1995) Substrates of hepatic cytochrome P450 3A4. Toxicology 104:1-8.
    • (1995) Toxicology , vol.104 , pp. 1-8
    • Li, A.P.1    Kaminski, D.L.2    Rasmussen, A.3
  • 21
    • 0019223734 scopus 로고
    • Buprenorphine suppresses heroin use by heroin addicts
    • Mello NK and Mendelson JH (1980) Buprenorphine suppresses heroin use by heroin addicts. Science 207:657-659.
    • (1980) Science , vol.207 , pp. 657-659
    • Mello, N.K.1    Mendelson, J.H.2
  • 23
    • 0029897059 scopus 로고    scopus 로고
    • Saquinavir: A review of its pharmacology and clinical potential in the management of HIV infection
    • Noble S and Faulds D (1996) Saquinavir: A review of its pharmacology and clinical potential in the management of HIV infection. Drugs 52:93-112.
    • (1996) Drugs , vol.52 , pp. 93-112
    • Noble, S.1    Faulds, D.2
  • 24
    • 0029549892 scopus 로고
    • Effect of fluoxetine, norfluoxetine, sertraline and desmethylsertraline on human CYP3A catalyzed 1′-hydroxy-midazolam formation in vitro
    • Ring BJ, Binkley SN, Roskos L and Wrighton SA (1995) Effect of fluoxetine, norfluoxetine, sertraline and desmethylsertraline on human CYP3A catalyzed 1′-hydroxy-midazolam formation in vitro. J Pharmacol Exp Ther 275:1131-1135.
    • (1995) J Pharmacol Exp Ther , vol.275 , pp. 1131-1135
    • Ring, B.J.1    Binkley, S.N.2    Roskos, L.3    Wrighton, S.A.4
  • 25
    • 0028237729 scopus 로고
    • Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals studies with liver microsomes of 30 Japanese and 30 Caucasians
    • Shimada T, Yamazaki H, Mimura M, Inui Y and Guengerich FP (1994) Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
    • (1994) J Pharmacol Exp Ther , vol.270 , pp. 414-423
    • Shimada, T.1    Yamazaki, H.2    Mimura, M.3    Inui, Y.4    Guengerich, F.P.5
  • 26
    • 0016712628 scopus 로고
    • Methadone in man: Pharmacokinetic and excretion studies in acute and chronic treatment
    • Verebely K, Volavka J. Mulé S and Resnick R (1975) Methadone in man: Pharmacokinetic and excretion studies in acute and chronic treatment. Clin Pharmacol Ther 18:180-190.
    • (1975) Clin Pharmacol Ther , vol.18 , pp. 180-190
    • Verebely, K.1    Volavka, J.2    Mulé, S.3    Resnick, R.4
  • 27
    • 0028194864 scopus 로고
    • Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants and by quinidine and ketoconazole: A model system to predict drug interactions in vivo
    • Von Moltke LL, Greenblatt DJ, Cotreau-Bibbo MM, Duan SX, Harmatz JS and Shader RI (1994) Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants and by quinidine and ketoconazole: A model system to predict drug interactions in vivo. J Pharmacol Exp Ther 268:1278-1283.
    • (1994) J Pharmacol Exp Ther , vol.268 , pp. 1278-1283
    • Von Moltke, L.L.1    Greenblatt, D.J.2    Cotreau-Bibbo, M.M.3    Duan, S.X.4    Harmatz, J.S.5    Shader, R.I.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.